GE HealthCare Technologies (GEHC) Cash & Current Investments (2022 - 2026)

GE HealthCare Technologies has reported Cash & Current Investments for 5 years, with the latest figure at $2.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 7.71% year-over-year to $2.3 billion; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (down 7.71% YoY), and the FY2025 full-year result was $4.5 billion, up 56.07% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $2.3 billion, down from $4.5 billion in the prior quarter.
• The five-year high for Cash & Current Investments was $4.5 billion in Q4 2025, with the low at $504.0 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $2.4 billion across 5 years, with a median of $2.4 billion in 2023.
• Annual changes were most pronounced in 2023 — Cash & Current Investments jumped 380.16% — and 2026, when it decreased 7.71%.
• GE HealthCare Technologies' Cash & Current Investments stood at $1.5 billion in 2022, then surged by 72.71% to $2.5 billion in 2023, then grew by 15.44% to $2.9 billion in 2024, then surged by 56.07% to $4.5 billion in 2025, then sank by 49.39% to $2.3 billion in 2026.
• The last three Cash & Current Investments figures came in at $2.3 billion (Q1 2026), $4.5 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.